Alkermes (ALKS) Liabilities and Shareholders Equity (2011 - 2026)

Alkermes (ALKS) has reported Liabilities and Shareholders Equity for 16 consecutive years, with $4.4 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity rose 95.01% year-over-year to $4.4 billion; the TTM figure through Jun 2026 stood at $13.5 billion (up 57.6% YoY), while the FY2025 annual figure was $2.5 billion, up 20.99% from the prior year.
• Liabilities and Shareholders Equity improved to $4.4 billion in Q2 2026 per ALKS's latest filing, from $4.3 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $4.4 billion in Q2 2026 and bottomed at $1.9 billion in Q1 2023.
• Historically, Liabilities and Shareholders Equity has averaged $2.4 billion across 5 years, with a median of $2.1 billion in 2023.
• Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity declined 5.44% — and 2026, when it soared 104.52%.
• Alkermes' Liabilities and Shareholders Equity stood at $2.0 billion in 2022, then grew by 8.77% to $2.1 billion in 2023, then slipped by 3.78% to $2.1 billion in 2024, then gained by 20.99% to $2.5 billion in 2025, then soared by 76.64% to $4.4 billion in 2026.
• Business Quant data shows ALKS's Liabilities and Shareholders Equity at $4.4 billion in Q2 2026, $4.3 billion in Q1 2026, and $2.5 billion in Q4 2025.